Ultra-low-molecular-weight Heparin (ULMWH) Semuloparin for Prevention of Venous Thromboembolism (VIE) in Cancer Patients Receiving Chemotherapy: Consistent Beneficial Effect Across Cancer Stage and Location Subgroups

被引：5

作者：

Agnelli, G. ^{[1
]}

George, D. ^{[2
,3
]}

Fisher, W. D. ^{[4
]}

Kakkar, A. K. ^{[5
,6
]}

Lassen, M. R. ^{[7
]}

Mismetti, P. ^{[8
]}

Mouret, P. ^{[9
]}

Lawson, F. ^{[10
]}

Turpie, A. G. G. ^{[11
]}

机构：

[1] Univ Perugia, I-06100 Perugia, Italy

[2] Duke Univ, Med Ctr, Div Med Oncol, Durham, NC 27706 USA

[3] Duke Univ, Med Ctr, Div Urol, Durham, NC 27706 USA

[4] McGill Univ, Dept Orthopaed Surg, Ctr Hlth, Montreal, PQ, Canada

[5] Thrombosis Res Inst, London SW3 6LR, England

[6] UCL, London, England

[7] Glostrup Cty Hosp, Glostrup, Denmark

[8] Univ St Etienne, Clin Pharmacol Unit, St Etienne, France

[9] Klinikum Frankfurt, Hochst, Germany

[10] Sanofi Aventis, R&D, Bridgewater, MA USA

[11] McMaster Univ, Hamilton, ON, Canada

来源：

关键词：

D O I：

10.1016/S0959-8049(11)71074-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S222 / S222

页数：1